Digital Inference of Immune Microenvironment Reveals "Low Risk" Subtype of Early Lung Adenocarcinoma.
Classification of lung adenocarcinoma (LUAD) currently relies on the TNM pathological staging system, which cannot fully account for the variability in post-surgery overall survival (OS). Despite the advances in immunotherapy and increased appreciation of the involvement of cancer immune microenvironment (IME) in cancer progression, the contribution of IME to post-surgery LUAD prognosis isn't well understood. We digitally inferred the contribution of 22 immune cell types/activation states to the tumor IME using CIBERSORT analysis in an exploratory metadataset of 581 patients with early stage LUAD. K-means clustering arranged patients based on similarity in IME. Relationship to post-surgical OS was tested in a univariable and multivariable models, using Kaplan Meyer Analysis and Cox-Proportional Hazard Modeling, respectively. To confirm survival relationships, a support-vector machine classifier was constructed from comparison of low and high-risk IME groups. The classifier was applied to a TCGA LUAD validation dataset of 394 patients. Patients with an inferred IME enriched in resting mast cells and depleted of macrophages represent a low clinical risk group in both exploratory and validation cohorts. Variability in the digitally inferred composition of the tumor IME contributes to heterogeneity in post-surgical OS. Our data suggest that low inferred macrophage content and inferred resting activation state of intra-tumor mast cells is associated with improved clinical outcome. Computational inference can be used to define LUAD risk groups and help guide clinical decision making.